Cargando…
Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV
BACKGROUND: Lopinavir is a specific reversible inhibitor of the enzyme HIV protease with mean oral bioavailability of less than 20% due to extensive hepatic metabolism by cytochrome P450 3A4. The reported half-life of Lopinavir is 5-6 hours and the maximum recommended daily dose is 400 mg/day. All t...
Autores principales: | Ansari, Huda, Singh, Prabha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416462/ https://www.ncbi.nlm.nih.gov/pubmed/30246641 http://dx.doi.org/10.2174/1570162X16666180924101650 |
Ejemplares similares
-
Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation
por: Shilakari Asthana, Gyati, et al.
Publicado: (2016) -
Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections
por: Nair, Anroop B., et al.
Publicado: (2021) -
Formulation and Evaluation of Optimized Oxybenzone Microsponge Gel for Topical Delivery
por: Pawar, Atmaram P., et al.
Publicado: (2015) -
Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery
por: Latif, Muhammad Shahid, et al.
Publicado: (2022) -
Simple spectrophotometric method for estimation of disodium edetate in topical gel formulations
por: Kamboj, Sunil, et al.
Publicado: (2011)